Global Favipiravir API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 109
Published Date: 29 Dec 2024
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Favipiravir API market size was valued at US$ 1602 million in 2023 and is forecast to a readjusted size of USD 2126 million by 2030 with a CAGR of 4.4% during review period.
Favipiravir API is a broad-spectrum antiviral drug with the chemical name 6-fluoro-3-hydroxy-pyrazine-2-carboxamide. It acts on the viral RNA-dependent RNA polymerase, accelerating virus clearance to alleviate viral infections. As an Active Pharmaceutical Ingredient (API) in the pharmaceutical industry, Favipiravir is used to treat diseases caused by various RNA viruses.
This report is a detailed and comprehensive analysis for global Favipiravir API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Favipiravir API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Favipiravir API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Favipiravir API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Favipiravir API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Favipiravir API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Favipiravir API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, Forewin Pharma, Senova Technology, Zhejiang Hengkang Pharmaceutical, Maithili Life Sciences, Hangzhou HETA Pharm & Chem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Favipiravir API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 98%
Purity < 98%
Market segment by Application
Pharmaceuticals
Scientific Research
Others
Major players covered
Chunghwa Chemical Synthesis & Biotech
TODACO
Tagoor Laboratories
Biophore
Lee Pharma
Forewin Pharma
Senova Technology
Zhejiang Hengkang Pharmaceutical
Maithili Life Sciences
Hangzhou HETA Pharm & Chem
Aurore Life Sciences
Bajaj Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Favipiravir API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Favipiravir API, with price, sales quantity, revenue, and global market share of Favipiravir API from 2019 to 2024.
Chapter 3, the Favipiravir API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Favipiravir API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Favipiravir API.
Chapter 14 and 15, to describe Favipiravir API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Favipiravir API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Purity ≥ 98%
1.3.3 Purity < 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Favipiravir API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceuticals
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Favipiravir API Market Size & Forecast
1.5.1 Global Favipiravir API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Favipiravir API Sales Quantity (2019-2030)
1.5.3 Global Favipiravir API Average Price (2019-2030)
2.1 Chunghwa Chemical Synthesis & Biotech
2.1.1 Chunghwa Chemical Synthesis & Biotech Details
2.1.2 Chunghwa Chemical Synthesis & Biotech Major Business
2.1.3 Chunghwa Chemical Synthesis & Biotech Favipiravir API Product and Services
2.1.4 Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
2.2 TODACO
2.2.1 TODACO Details
2.2.2 TODACO Major Business
2.2.3 TODACO Favipiravir API Product and Services
2.2.4 TODACO Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 TODACO Recent Developments/Updates
2.3 Tagoor Laboratories
2.3.1 Tagoor Laboratories Details
2.3.2 Tagoor Laboratories Major Business
2.3.3 Tagoor Laboratories Favipiravir API Product and Services
2.3.4 Tagoor Laboratories Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Tagoor Laboratories Recent Developments/Updates
2.4 Biophore
2.4.1 Biophore Details
2.4.2 Biophore Major Business
2.4.3 Biophore Favipiravir API Product and Services
2.4.4 Biophore Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biophore Recent Developments/Updates
2.5 Lee Pharma
2.5.1 Lee Pharma Details
2.5.2 Lee Pharma Major Business
2.5.3 Lee Pharma Favipiravir API Product and Services
2.5.4 Lee Pharma Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lee Pharma Recent Developments/Updates
2.6 Forewin Pharma
2.6.1 Forewin Pharma Details
2.6.2 Forewin Pharma Major Business
2.6.3 Forewin Pharma Favipiravir API Product and Services
2.6.4 Forewin Pharma Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Forewin Pharma Recent Developments/Updates
2.7 Senova Technology
2.7.1 Senova Technology Details
2.7.2 Senova Technology Major Business
2.7.3 Senova Technology Favipiravir API Product and Services
2.7.4 Senova Technology Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Senova Technology Recent Developments/Updates
2.8 Zhejiang Hengkang Pharmaceutical
2.8.1 Zhejiang Hengkang Pharmaceutical Details
2.8.2 Zhejiang Hengkang Pharmaceutical Major Business
2.8.3 Zhejiang Hengkang Pharmaceutical Favipiravir API Product and Services
2.8.4 Zhejiang Hengkang Pharmaceutical Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
2.9 Maithili Life Sciences
2.9.1 Maithili Life Sciences Details
2.9.2 Maithili Life Sciences Major Business
2.9.3 Maithili Life Sciences Favipiravir API Product and Services
2.9.4 Maithili Life Sciences Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Maithili Life Sciences Recent Developments/Updates
2.10 Hangzhou HETA Pharm & Chem
2.10.1 Hangzhou HETA Pharm & Chem Details
2.10.2 Hangzhou HETA Pharm & Chem Major Business
2.10.3 Hangzhou HETA Pharm & Chem Favipiravir API Product and Services
2.10.4 Hangzhou HETA Pharm & Chem Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hangzhou HETA Pharm & Chem Recent Developments/Updates
2.11 Aurore Life Sciences
2.11.1 Aurore Life Sciences Details
2.11.2 Aurore Life Sciences Major Business
2.11.3 Aurore Life Sciences Favipiravir API Product and Services
2.11.4 Aurore Life Sciences Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Aurore Life Sciences Recent Developments/Updates
2.12 Bajaj Healthcare
2.12.1 Bajaj Healthcare Details
2.12.2 Bajaj Healthcare Major Business
2.12.3 Bajaj Healthcare Favipiravir API Product and Services
2.12.4 Bajaj Healthcare Favipiravir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bajaj Healthcare Recent Developments/Updates
3.1 Global Favipiravir API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Favipiravir API Revenue by Manufacturer (2019-2024)
3.3 Global Favipiravir API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Favipiravir API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Favipiravir API Manufacturer Market Share in 2023
3.4.3 Top 6 Favipiravir API Manufacturer Market Share in 2023
3.5 Favipiravir API Market: Overall Company Footprint Analysis
3.5.1 Favipiravir API Market: Region Footprint
3.5.2 Favipiravir API Market: Company Product Type Footprint
3.5.3 Favipiravir API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Favipiravir API Market Size by Region
4.1.1 Global Favipiravir API Sales Quantity by Region (2019-2030)
4.1.2 Global Favipiravir API Consumption Value by Region (2019-2030)
4.1.3 Global Favipiravir API Average Price by Region (2019-2030)
4.2 North America Favipiravir API Consumption Value (2019-2030)
4.3 Europe Favipiravir API Consumption Value (2019-2030)
4.4 Asia-Pacific Favipiravir API Consumption Value (2019-2030)
4.5 South America Favipiravir API Consumption Value (2019-2030)
4.6 Middle East & Africa Favipiravir API Consumption Value (2019-2030)
5.1 Global Favipiravir API Sales Quantity by Type (2019-2030)
5.2 Global Favipiravir API Consumption Value by Type (2019-2030)
5.3 Global Favipiravir API Average Price by Type (2019-2030)
6.1 Global Favipiravir API Sales Quantity by Application (2019-2030)
6.2 Global Favipiravir API Consumption Value by Application (2019-2030)
6.3 Global Favipiravir API Average Price by Application (2019-2030)
7.1 North America Favipiravir API Sales Quantity by Type (2019-2030)
7.2 North America Favipiravir API Sales Quantity by Application (2019-2030)
7.3 North America Favipiravir API Market Size by Country
7.3.1 North America Favipiravir API Sales Quantity by Country (2019-2030)
7.3.2 North America Favipiravir API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Favipiravir API Sales Quantity by Type (2019-2030)
8.2 Europe Favipiravir API Sales Quantity by Application (2019-2030)
8.3 Europe Favipiravir API Market Size by Country
8.3.1 Europe Favipiravir API Sales Quantity by Country (2019-2030)
8.3.2 Europe Favipiravir API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Favipiravir API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Favipiravir API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Favipiravir API Market Size by Region
9.3.1 Asia-Pacific Favipiravir API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Favipiravir API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Favipiravir API Sales Quantity by Type (2019-2030)
10.2 South America Favipiravir API Sales Quantity by Application (2019-2030)
10.3 South America Favipiravir API Market Size by Country
10.3.1 South America Favipiravir API Sales Quantity by Country (2019-2030)
10.3.2 South America Favipiravir API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Favipiravir API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Favipiravir API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Favipiravir API Market Size by Country
11.3.1 Middle East & Africa Favipiravir API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Favipiravir API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Favipiravir API Market Drivers
12.2 Favipiravir API Market Restraints
12.3 Favipiravir API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Favipiravir API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Favipiravir API
13.3 Favipiravir API Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Favipiravir API Typical Distributors
14.3 Favipiravir API Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Favipiravir API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Favipiravir API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Chunghwa Chemical Synthesis & Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Chunghwa Chemical Synthesis & Biotech Major Business
Table 5. Chunghwa Chemical Synthesis & Biotech Favipiravir API Product and Services
Table 6. Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
Table 8. TODACO Basic Information, Manufacturing Base and Competitors
Table 9. TODACO Major Business
Table 10. TODACO Favipiravir API Product and Services
Table 11. TODACO Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. TODACO Recent Developments/Updates
Table 13. Tagoor Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Tagoor Laboratories Major Business
Table 15. Tagoor Laboratories Favipiravir API Product and Services
Table 16. Tagoor Laboratories Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Tagoor Laboratories Recent Developments/Updates
Table 18. Biophore Basic Information, Manufacturing Base and Competitors
Table 19. Biophore Major Business
Table 20. Biophore Favipiravir API Product and Services
Table 21. Biophore Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biophore Recent Developments/Updates
Table 23. Lee Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Lee Pharma Major Business
Table 25. Lee Pharma Favipiravir API Product and Services
Table 26. Lee Pharma Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Lee Pharma Recent Developments/Updates
Table 28. Forewin Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Forewin Pharma Major Business
Table 30. Forewin Pharma Favipiravir API Product and Services
Table 31. Forewin Pharma Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Forewin Pharma Recent Developments/Updates
Table 33. Senova Technology Basic Information, Manufacturing Base and Competitors
Table 34. Senova Technology Major Business
Table 35. Senova Technology Favipiravir API Product and Services
Table 36. Senova Technology Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Senova Technology Recent Developments/Updates
Table 38. Zhejiang Hengkang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhejiang Hengkang Pharmaceutical Major Business
Table 40. Zhejiang Hengkang Pharmaceutical Favipiravir API Product and Services
Table 41. Zhejiang Hengkang Pharmaceutical Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
Table 43. Maithili Life Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Maithili Life Sciences Major Business
Table 45. Maithili Life Sciences Favipiravir API Product and Services
Table 46. Maithili Life Sciences Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Maithili Life Sciences Recent Developments/Updates
Table 48. Hangzhou HETA Pharm & Chem Basic Information, Manufacturing Base and Competitors
Table 49. Hangzhou HETA Pharm & Chem Major Business
Table 50. Hangzhou HETA Pharm & Chem Favipiravir API Product and Services
Table 51. Hangzhou HETA Pharm & Chem Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Hangzhou HETA Pharm & Chem Recent Developments/Updates
Table 53. Aurore Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Aurore Life Sciences Major Business
Table 55. Aurore Life Sciences Favipiravir API Product and Services
Table 56. Aurore Life Sciences Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Aurore Life Sciences Recent Developments/Updates
Table 58. Bajaj Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Bajaj Healthcare Major Business
Table 60. Bajaj Healthcare Favipiravir API Product and Services
Table 61. Bajaj Healthcare Favipiravir API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Bajaj Healthcare Recent Developments/Updates
Table 63. Global Favipiravir API Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 64. Global Favipiravir API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Favipiravir API Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 66. Market Position of Manufacturers in Favipiravir API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 67. Head Office and Favipiravir API Production Site of Key Manufacturer
Table 68. Favipiravir API Market: Company Product Type Footprint
Table 69. Favipiravir API Market: Company Product Application Footprint
Table 70. Favipiravir API New Market Entrants and Barriers to Market Entry
Table 71. Favipiravir API Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Favipiravir API Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 73. Global Favipiravir API Sales Quantity by Region (2019-2024) & (Tons)
Table 74. Global Favipiravir API Sales Quantity by Region (2025-2030) & (Tons)
Table 75. Global Favipiravir API Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Global Favipiravir API Consumption Value by Region (2025-2030) & (USD Million)
Table 77. Global Favipiravir API Average Price by Region (2019-2024) & (US$/Ton)
Table 78. Global Favipiravir API Average Price by Region (2025-2030) & (US$/Ton)
Table 79. Global Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 80. Global Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 81. Global Favipiravir API Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Global Favipiravir API Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Global Favipiravir API Average Price by Type (2019-2024) & (US$/Ton)
Table 84. Global Favipiravir API Average Price by Type (2025-2030) & (US$/Ton)
Table 85. Global Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 86. Global Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 87. Global Favipiravir API Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Global Favipiravir API Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Global Favipiravir API Average Price by Application (2019-2024) & (US$/Ton)
Table 90. Global Favipiravir API Average Price by Application (2025-2030) & (US$/Ton)
Table 91. North America Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 92. North America Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 93. North America Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 94. North America Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 95. North America Favipiravir API Sales Quantity by Country (2019-2024) & (Tons)
Table 96. North America Favipiravir API Sales Quantity by Country (2025-2030) & (Tons)
Table 97. North America Favipiravir API Consumption Value by Country (2019-2024) & (USD Million)
Table 98. North America Favipiravir API Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Europe Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 100. Europe Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 101. Europe Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 102. Europe Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 103. Europe Favipiravir API Sales Quantity by Country (2019-2024) & (Tons)
Table 104. Europe Favipiravir API Sales Quantity by Country (2025-2030) & (Tons)
Table 105. Europe Favipiravir API Consumption Value by Country (2019-2024) & (USD Million)
Table 106. Europe Favipiravir API Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Asia-Pacific Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 108. Asia-Pacific Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 109. Asia-Pacific Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 110. Asia-Pacific Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 111. Asia-Pacific Favipiravir API Sales Quantity by Region (2019-2024) & (Tons)
Table 112. Asia-Pacific Favipiravir API Sales Quantity by Region (2025-2030) & (Tons)
Table 113. Asia-Pacific Favipiravir API Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Asia-Pacific Favipiravir API Consumption Value by Region (2025-2030) & (USD Million)
Table 115. South America Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 116. South America Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 117. South America Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 118. South America Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 119. South America Favipiravir API Sales Quantity by Country (2019-2024) & (Tons)
Table 120. South America Favipiravir API Sales Quantity by Country (2025-2030) & (Tons)
Table 121. South America Favipiravir API Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Favipiravir API Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Favipiravir API Sales Quantity by Type (2019-2024) & (Tons)
Table 124. Middle East & Africa Favipiravir API Sales Quantity by Type (2025-2030) & (Tons)
Table 125. Middle East & Africa Favipiravir API Sales Quantity by Application (2019-2024) & (Tons)
Table 126. Middle East & Africa Favipiravir API Sales Quantity by Application (2025-2030) & (Tons)
Table 127. Middle East & Africa Favipiravir API Sales Quantity by Country (2019-2024) & (Tons)
Table 128. Middle East & Africa Favipiravir API Sales Quantity by Country (2025-2030) & (Tons)
Table 129. Middle East & Africa Favipiravir API Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Middle East & Africa Favipiravir API Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Favipiravir API Raw Material
Table 132. Key Manufacturers of Favipiravir API Raw Materials
Table 133. Favipiravir API Typical Distributors
Table 134. Favipiravir API Typical Customers
List of Figures
Figure 1. Favipiravir API Picture
Figure 2. Global Favipiravir API Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Favipiravir API Revenue Market Share by Type in 2023
Figure 4. Purity ≥ 98% Examples
Figure 5. Purity < 98% Examples
Figure 6. Global Favipiravir API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Favipiravir API Revenue Market Share by Application in 2023
Figure 8. Pharmaceuticals Examples
Figure 9. Scientific Research Examples
Figure 10. Others Examples
Figure 11. Global Favipiravir API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Favipiravir API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Favipiravir API Sales Quantity (2019-2030) & (Tons)
Figure 14. Global Favipiravir API Price (2019-2030) & (US$/Ton)
Figure 15. Global Favipiravir API Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Favipiravir API Revenue Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Favipiravir API by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 18. Top 3 Favipiravir API Manufacturer (Revenue) Market Share in 2023
Figure 19. Top 6 Favipiravir API Manufacturer (Revenue) Market Share in 2023
Figure 20. Global Favipiravir API Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Favipiravir API Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Favipiravir API Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Favipiravir API Average Price by Type (2019-2030) & (US$/Ton)
Figure 30. Global Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Favipiravir API Revenue Market Share by Application (2019-2030)
Figure 32. Global Favipiravir API Average Price by Application (2019-2030) & (US$/Ton)
Figure 33. North America Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Favipiravir API Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Favipiravir API Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Favipiravir API Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Favipiravir API Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 45. France Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Favipiravir API Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Favipiravir API Consumption Value Market Share by Region (2019-2030)
Figure 53. China Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 56. India Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Favipiravir API Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Favipiravir API Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Favipiravir API Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Favipiravir API Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Favipiravir API Sales Quantity Market Share by Country (2019-2030)
Figure 68. Middle East & Africa Favipiravir API Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 70. Egypt Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 72. South Africa Favipiravir API Consumption Value (2019-2030) & (USD Million)
Figure 73. Favipiravir API Market Drivers
Figure 74. Favipiravir API Market Restraints
Figure 75. Favipiravir API Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Favipiravir API in 2023
Figure 78. Manufacturing Process Analysis of Favipiravir API
Figure 79. Favipiravir API Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Chunghwa Chemical Synthesis & Biotech TODACO Tagoor Laboratories Biophore Lee Pharma Forewin Pharma Senova Technology Zhejiang Hengkang Pharmaceutical Maithili Life Sciences Hangzhou HETA Pharm & Chem Aurore Life Sciences Bajaj Healthcare
29 Dec 2024
Chemical & Material
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
